Any feedback?
Literature summary for 3.4.14.5 extracted from
- Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure (2008), Clin. Exp. Pharmacol. Physiol., 35, 29-34.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | in genetically susceptible animals, inhibition of DPP IV increases arterial blood pressure via Y1 receptors when elevated blood pressure is reduced with antihypertensive drugs provided that the sympathetic nervous system is functional | Rattus norvegicus |
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| 3-N-[(2S,3S)-2-amino-3-methylpentanoyl]-1,3-thiazolidine | in genetically susceptible animals, inhibition of DPP IV increases arterial blood pressure via Y1 receptors when elevated blood pressure is reduced with antihypertensive drugs provided that the sympathetic nervous system is functional | Rattus norvegicus |  |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Rattus norvegicus | - |
- |
- |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| CD26 | - |
Rattus norvegicus |
| dipeptidyl peptidase IV | - |
Rattus norvegicus |
| DPP IV | - |
Rattus norvegicus |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
